Medpace Holdings, Inc. (MEDP) News
Filter MEDP News Items
MEDP News Results
|Loading, please wait...|
MEDP News Highlights
- MEDP's 30 day story count now stands at 31.
- Over the past 20 days, the trend for MEDP's stories per day has been choppy and unclear. It has oscillated between 1 and 12.
- The most mentioned tickers in articles about MEDP are BEAT, CBOE and FL.
Latest MEDP News From Around the Web
Below are the latest news stories about Medpace Holdings Inc that investors may wish to consider to help them evaluate MEDP as an investment opportunity.
Investment Thesis Big-volume “block” stock trades require negotiated off-exchange-floor “facilitations” of market liquidity by market-making firms to promptly balance supply-demand disparities as market anticipations evolve. The resulting MM capital risks are hedged by deals in derivative securities to offset price changes in the underlying stock until those temporary positions can...
In this article, we will take a look at the 10 stocks making big moves after releasing their financial results. You can skip our detailed analysis of these companies and go directly to the 5 Stocks Making Big Moves After Releasing Their Financial Results. The fourth-quarter earnings season is winding down. Henry Schein, Inc. (NASDAQ:HSIC), […]
MEDP earnings call for the period ending December 31, 2021.
In the last trading session, 2.26 million shares of the Medpace Holdings Inc. (NASDAQ:MEDP) were traded, and its beta was 1.44. Most recently the company’s share price was $138.87, and it changed around -$35.36 or -20.30% from the last close, which brings the market valuation of the company to $5.03B. MEDP currently trades at a … Medpace Holdings Inc. (NASDAQ: MEDP) Could See Prices Soar In The Coming Months Read More »
The heavy selling pressure might have exhausted for Medpace (MEDP) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Medpace Holdings Inc''s (NASDAQ: MEDP ) Q4 revenue increased 18.8% Y/Y to $308.6 million , missing the consensus of $309.04 million. On a constant currency organic basis, revenue increased 19.2%. As of December 31, 2021, Backlog grew 29.5% to $1.99 billion. Net new business awards were $458.7 million, representing a net … Full story available on Benzinga.com
Although Medpace Holdings (MEDP) Q4 2021 results beat on the bottom line, its stock price took a licking today as some investors may have been disappointed by its FY 2022 outlook.
No summary available.
No summary available.
CINCINNATI--(BUSINESS WIRE)--Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced financial results for the fourth quarter and full year ended December 31, 2021. Fourth Quarter and Full Year 2021 Financial Results Revenue for the three months ended December 31, 2021 increased 18.8% to $308.6 million, compared to $259.7 million for the comparable prior-year period. Revenue for the year ended December 31, 2021 increased 23.4% to $1,142.4 million, compared to $925.9 million for the ye